financetom
Business
financetom
/
Business
/
Cheesecake Factory Likely to Report 'Solid' Q4, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cheesecake Factory Likely to Report 'Solid' Q4, UBS Says
Feb 18, 2025 12:17 PM

02:58 PM EST, 02/18/2025 (MT Newswires) -- Cheesecake Factory ( CAKE ) is likely to report "solid" Q4 same-store sales when it report its earnings, UBS said in a note emailed Tuesday.

UBS said Q4 same-store sales would roughly be in line with expectations. The company's investors are expecting same-store sales of around 1.5%, while analysts have pegged it at 1.6%, according to UBS.

The company's Q4 margins are also likely to be in line with consensus and UBS said it expects Cheesecake Factory ( CAKE ) to reiterate most of its 2025 guidance.

The investment bank said it expects Q4 revenue of $915.6 million, slightly above the consensus of $912.5 million and also higher than the company's guidance of $905 million to $915 million.

"We expect contribution from marketing, improving guest satisfaction scores, loyalty, and a higher income customer base, with mix headwinds likely to have continued to abate," UBS wrote.

Still, the firm said it was "somewhat cautious" on 2025 given the risk to same-store sales "from a still challenging macro and competitive factors."

The firm has a sell rating on the stock with a price target of $41.

Price: 55.14, Change: +1.80, Percent Change: +3.37

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved